Ellagitannins Cancer Research Results

ETs, Ellagitannins: Click to Expand ⟱
Features:

Ellagitannins

Ellagitannins are high-molecular-weight hydrolyzable polyphenols found in pomegranates, berries, walnuts and several other plant foods. Chemically, they contain hexahydroxydiphenoyl (HHDP) or related groups esterified to a carbohydrate core.

Ellagitannins can undergo hydrolysis to release ellagic acid. Intestinal bacteria can subsequently convert ellagic acid into urolithins, including urolithin A and urolithin B. These microbial metabolites may be important mediators of the biological effects associated with ellagitannin-rich foods.

Their cancer-related research includes modulation of inflammatory signaling, cell proliferation, apoptosis, mitochondrial function and the tumor microenvironment.

Main Potential Anticancer Mechanisms

  • Modulation of NF-kB signaling and inflammatory pathways.
  • Induction of apoptosis in experimental cancer models.
  • Modulation of PI3K/AKT and related survival pathways.
  • Regulation of ROS and oxidative-stress responses.
  • Experimental effects on mitochondrial function, mitophagy and cellular metabolism, particularly for urolithin metabolites.
  • Potential modulation of antitumor immune responses and the gut microbiome.

Representative Ellagitannins

  • Castalagin - ellagitannin investigated for immunomodulatory and experimental anticancer properties.
  • Punicalagin - major ellagitannin of pomegranate, including alpha and beta isomers.
  • Pedunculagin - ellagitannin found in several plant species.
  • Sanguiin H-6 - ellagitannin occurring in raspberries and related fruits.

Related Hydrolysis Products and Metabolites

  • Ellagic acid - polyphenolic compound released by hydrolysis of ellagitannins.
  • Urolithins - gut microbiota-derived metabolites of ellagic acid.

Principal Food Sources: Pomegranate, walnuts, raspberries, strawberries, blackberries and selected other nuts and berries.

Bioavailability: Intact ellagitannins generally have limited systemic absorption. Urolithin production varies substantially between individuals because of differences in gut microbiota.

Evidence: Primarily preclinical studies, with some human dietary and biomarker research. Evidence for improved cancer outcomes remains insufficient.



Scientific Papers found: Click to Expand⟱
Showing Research Papers: 0 to 0 of 0

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 0

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Total Targets: 0

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:535  Target#:%  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page